Idiopathic pulmonary fibrosis is associated with a preferential alteration of kCO rather than of DLCO

J. Pastre, C. Delclaux, S. Roussel, K. Juvin, J. Valcke, D. Israel-Biet (Paris, France)

Source: International Congress 2014 – ILDs 6
Session: ILDs 6
Session type: Thematic Poster Session
Number: 3787
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Abstract

INTRODUCTION: Interstitial lung diseases (ILD) are a heterogeneous group of disorders generally sharing physiologic abnormalities such as restrictive ventilatory defect andreduced diffusing capacity for carbon monoxide (DLCO). In idiopathic pulmonary fibrosis (IPF), DLCO, product of two primary measurements during breath-holding: CO transfer coefficient (kCO) and alveolar volume (VA), is considered to be more informative than kCO in predicting gas exchange modifications. We aimed at comparing the relevance of both kCO and DLCO in IPF and other ILDs.MATERIAL AND METHODS: We retrospectively studied 84 patients with ILD: groups 1 (IPF: n=26), 2 (stage IV sarcoidosis: n=17), and 3 (other fibrosing ILD: n=41). All had performed HRCT and pulmonary function tests (PFT) including spirometry, plethysmography, kCO and VA measurements. Statistical analysis was performed using Kruskall-Wallis test.RESULTS: IPF pts were older (73±13 yrs) than the 2 other groups (p<0.0001). TLC and FVC were similar in the 3 groups : TLC = 70+21%, 72+20% and 80+18% predicted, respectively, and ; FVC = 75±25, 69±24%, 74±20% predicted, respectively, in gr 1, 2 and 3 (NS). In contrast, while DLCO was also similar in the 3 groups, kCO was clearly decreased in IPF alone (p<0.01). A marked basal predominance of fibrotic lesions on HRCT was associated with a lower kCO but with no difference in DLCO.CONCLUSION: IPF is associated with a preferential alteration of kCO rather than of DLCO, reflecting the major implication of alveolo-capillary membrane disorders in this disease. kCO provides more hints to IPF pathophysiology and might be helpful to differential diagnosis of ILD with no CT scan pattern typical of IPF.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Pastre, C. Delclaux, S. Roussel, K. Juvin, J. Valcke, D. Israel-Biet (Paris, France). Idiopathic pulmonary fibrosis is associated with a preferential alteration of kCO rather than of DLCO. Eur Respir J 2014; 44: Suppl. 58, 3787

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Assessment of telomere length in the combined pulmonary fibrosis and emphysema syndrome
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014


Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2014 – ILDs 5
Year: 2014


Predictors of efficacy of pirfenidone in idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 4
Year: 2014


6MWT performance by means of Spiropalm in patients affected by fibrotic idiopathic interstitial pneumonias: Preliminary observations
Source: International Congress 2014 – ILDs 6
Year: 2014


Safety and efficacy of pirfenidone in severe idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 3
Year: 2014


Comparison of physiological impairment in ILD patients with and without diagnostic IPF features
Source: International Congress 2014 – ILDs 4
Year: 2014


Pirfenidone in idiopathic pulmonary fibrosis - description of a German cohort
Source: International Congress 2014 – ILDs 4
Year: 2014


Dissecting the role of TRPC6-channels in bleomycin-induced pulmonary fibrosis
Source: International Congress 2014 – ILDs 3
Year: 2014

Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – ILDs 3
Year: 2014


Lung 18F-FDG uptake correlates with lung function alteration in patients with IPF
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014


Transient elastography detection of early liver fibrosis in idiopathic pulmonary fibrosis patients
Source: International Congress 2014 – ILDs 2
Year: 2014


Analysis of candidate genes of phenotypic expression in idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 5
Year: 2014


IPFdatabase – A new tool for a correct application of idiopathic pulmonary fibrosis guidelines
Source: International Congress 2014 – ILDs 2
Year: 2014

Pulmonary distribution and localization of pirfenidone in animal models of IPF by MS/MS
Source: International Congress 2014 – ILDs 4
Year: 2014

Diffuse dendriform pulmonary ossification in a usual interstitial pneumonia-like distribution: A distinct entity or a variant of idiopathic pulmonary fibrosis?
Source: International Congress 2014 – ILDs 1
Year: 2014


The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE)
Source: International Congress 2014 – ILDs 1
Year: 2014


Surfactant protein B proforms as potential new biomarkers for idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 2
Year: 2014

LATE-BREAKING ABSTRACT: The effects and mechanism of adiponectin on inhibiting pulmonary fibrosis
Source: International Congress 2014 – ILDs 1
Year: 2014


Evolution of an interstitial lung disease MDT: 5.5 years of data
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014


Prognostic influence of comorbidities in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – ILDs 2
Year: 2014